Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Geron Corp (GERN)

Geron Corp (GERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Geron: Q2 Earnings Snapshot AP - Wed Aug 5, 6:33AM CDT

Geron: Q2 Earnings Snapshot

GERN : 1.5350 (-2.23%)
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights GlobeNewswire - Wed Aug 5, 6:00AM CDT

Achieved $57.5 million in RYTELO ® (imetelstat) net product revenue in Q2 2026, an increase of 11% compared to Q1 2026 Reiterated 2026 RYTELO net product revenue and total operating expenses...

GERN : 1.5350 (-2.23%)
Geron's Estimate Revisions Suggest Analysts Are Adjusting to Something Barchart - Tue Aug 4, 4:15PM CDT

Barchart Research What to Expect from GERN Earnings GERN Generated August 4, 2026 Current Price $1.3400 EPS Estimate $$-0.01 Consensus Rating Moderate Buy Average Move 8.91% Geron's Estimate Revisions...

GERN : 1.5350 (-2.23%)
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Jul 22, 3:01PM CDT

FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective July 17, 2026, it granted stock options...

GERN : 1.5350 (-2.23%)
Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire - Wed Jul 22, 6:00AM CDT

FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

GERN : 1.5350 (-2.23%)
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Jul 14, 3:26PM CDT

FOSTER CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a...

GERN : 1.5350 (-2.23%)
Geron Announces Appointment of Chinmaya Rath as Chief Business Officer GlobeNewswire - Mon Jul 13, 7:00AM CDT

FOSTER CITY, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

GERN : 1.5350 (-2.23%)
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Thu Jun 18, 3:01PM CDT

FOSTER CITY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective June 17, 2026, it granted stock options...

GERN : 1.5350 (-2.23%)
Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire - Mon Jun 1, 7:00AM CDT

FOSTER CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

GERN : 1.5350 (-2.23%)
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets FinancialNewsMedia - Wed May 20, 8:45AM CDT

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:BIOA),(NYSE:LCTX),(NASDAQ:FATE) EQNX::TICKER_END

AVAI : 0.1221 (+1.67%)
BIOA : 11.65 (+3.37%)
LCTX : 1.1300 (+0.88%)
GERN : 1.5350 (-2.23%)
FATE : 2.51 (+0.80%)

Barchart Exclusives

Netflix Looks Attractive to Short-Put Players - a 2.0% One Month Income Yield Barchart - 1 hour ago
Netflix stock looks attractive to value investors, especially to out-of-the-money (OTM) short-put investors. For example, a 2.0% yield for one month is available on a put option with a 5% lower strike price. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.